MALLORY DRAKE: Open Payments
NPI 1366044844 · NORCROSS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,691 in 108 payments from 12 companies in 2025. Trend: 2023 $595 · 2024 $1,074 · 2025 $1,691
Food & beverage: $1,580Education: $111
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 27 | $386 |
| Neurocrine BioSciences, Inc. | 6 | $274 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $187 |
| Teva Pharmaceuticals USA, Inc. | 6 | $163 |
| Noven Therapeutics, LLC | 12 | $145 |
| ABBVIE INC. | 14 | $144 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Tris Pharma Inc | 3 | $49 |
Products named: Qelbree, INGREZZA, CAPLYTA, TRINTELLIX, VRAYLAR, Xelstrym, SPRAVATO, Secuado.
Industry payments across GA — which companies pay providers there.
